Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LOC102724642 (ENSG00000204745) encodes a pseudogene of the anaphase-promoting complex subunit 1; it does not produce a functional protein and is not involved directly in any canonical molecular pathway or protein complex[5][6]. Pseudogenes are stretches of DNA similar to functional genes that have lost their protein-coding ability due to mutations, deletions, or other genomic changes[2][6]. While traditionally considered non-functional, emerging research shows that some pseudogenes can be transcribed into RNA and potentially influence biological processes such as gene regulation; they may act via RNA interference, microRNA sponging, or modulation of gene expression through antisense transcripts[2]. There is no evidence that this pseudogene is a therapeutic target, or that it interacts with any drug or serves as a biomarker, and no safety issues are associated with it. Pseudogenes of other genes have been implicated in regulatory roles in cancer, diabetes, and other diseases, but no specific role for LOC102724642 in disease biology is described in current resources[2].
null
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Anaphase-promoting complex subunit 1 pseudogene (null).